Author pages are created from data sourced from our academic publisher partnerships and public sources.
Eosinophilic esophagitis: updated consensus recommendations for children and adults.
- C. Liacouras, G. Furuta, +30 authors S. Aceves
- The Journal of allergy and clinical immunology
- 1 July 2011
Eosinophilic esophagitis (EoE) is a clinicopathologic condition of increasing recognition and prevalence. In 2007, a consensus recommendation provided clinical and histopathologic guidance for the… Expand
ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus
- N. Shaheen, G. Falk, P. Iyer, L. Gerson
- The American Journal of Gastroenterology
- 1 January 2016
Barrett’s esophagus (BE) is among the most common conditions encountered by the gastroenterologist. In this document, the American College of Gastroenterology updates its guidance for the best… Expand
A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop.
BACKGROUND & AIMS The diagnosis and management of Barrett's esophagus (BE) are controversial. We conducted a critical review of the literature in BE to provide guidance on clinically relevant issues.… Expand
Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.
- P. Sharma, G. Falk, A. Weston, D. Reker, M. Johnston, R. Sampliner
- Clinical gastroenterology and hepatology : the…
- 1 May 2006
BACKGROUND & AIMS The exact incidence of adenocarcinoma in patients with Barrett's esophagus (BE) is not known and is reported to vary from 0.2%-2% per year. Published series of patients with BE have… Expand
Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection.
BACKGROUND & AIMS Whether inflammation of the cardia indicates gastroesophageal reflux disease (GERD) and/or is a manifestation of pangastritis caused by Helicobacter pylori infection is unknown. The… Expand
Radiofrequency ablation in Barrett's esophagus with dysplasia.
- N. Shaheen, P. Sharma, +30 authors C. Lightdale
- The New England journal of medicine
- 28 May 2009
BACKGROUND Barrett's esophagus, a condition of intestinal metaplasia of the esophagus, is associated with an increased risk of esophageal adenocarcinoma. We assessed whether endoscopic radiofrequency… Expand
Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach.
The histological distinction between intestinal metaplasia involving the distal esophagus (Barrett's esophagus [BE]) and intestinal metaplasia of the stomach has important clinical implications and… Expand
Thymic stromal lymphopoietin–elicited basophil responses promote eosinophilic esophagitis
Eosinophilic esophagitis (EoE) is a food allergy–associated inflammatory disease characterized by esophageal eosinophilia. Current management strategies for EoE are nonspecific, and thus there is a… Expand
Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.
BACKGROUND & AIMS Radiofrequency ablation (RFA) can eradicate dysplasia and intestinal metaplasia in patients with dysplastic Barrett's esophagus (BE), and reduce rates of esophageal adenocarcinoma.… Expand
Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial
- P. Kahrilas, G. Falk, +6 authors B. Joelsson
- Alimentary pharmacology & therapeutics
- 1 October 2000
The pharmacologic profile of the new proton pump inhibitor esomeprazole has demonstrated advantages over omeprazole that suggest clinical benefits for patients with acid‐related disease.